Quick highlights
- Tumor marker mainly used for monitoring, not screening
- Trend tracking over time is more useful than single values
- Can rise in benign conditions (endometriosis, inflammation, menstruation)
- Interpreted alongside imaging and clinical exam
- No fasting usually required
- Helpful for treatment response monitoring under oncologist guidance
- Avoids alarmist interpretation; emphasizes limitations
- Home blood collection available in many service areas
- Useful for documenting baseline and follow-up trends
- SEO coverage: CA125 test, ovarian cancer marker CA-125 monitoring
What’s included
Preparation
- Book blood draw (home or lab)
- No fasting unless combined tests require fasting
- Tell clinician about menstrual cycle timing, pregnancy, or pelvic conditions
- Disclose recent pelvic procedures or infections
- Collect serum blood sample via trained phlebotomist
- Download report from <a href='/my-account/'>View reports</a>
- Review trends with clinician/oncologist
- Follow clinician plan for imaging and follow-up
FAQs
A tumor marker that may be used to monitor certain gynecologic cancer contexts under clinician care.
No. It is not recommended as a routine screening test for the general population.
Usually no.
Yes, benign gynecologic conditions and menstruation can increase CA-125; clinicians interpret with context.
No. It is not diagnostic and requires clinical evaluation and imaging.
To monitor trends and treatment response; changes over time can be more informative.
Often same day or within 24 hours.
Serum blood sample.
Yes in many serviceable areas.
Discuss with your clinician; single values can be misleading.
Imaging (ultrasound/CT/MRI) and other clinician-directed evaluations.
It may be elevated in benign inflammation; clinicians interpret accordingly.
Download from <a href='/my-account/'>View reports</a>.
Persistent bloating, pelvic pain, early satiety, or unexplained weight changes warrant clinician review.
Notes
CA-125 levels can rise in benign conditions; interpret cautiously.
